The Conference Forum
- Company typePrivate
- Founded2011
- HeadquartersNew York, United States
- Headcount11–50
- GTM typeB2B
- OfferingServices
The Conference Forum firmographics
Firmographics- Name
- The Conference Forum
- Legal name
- The Conference Forum
- Website
- https://theconferenceforum.org
- Company type
- Private
- Founded year
- 2011
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Ownership category
- akta.pro rank
The Conference Forum industry classification
Industry- Product category
- Life Sciences Conferences and Events
- NAICS
- Scientific Research and Development Services (5417), Professional, Scientific, and Technical Services (541)
- SIC
- Services-Commercial Physical & Biological Research (8731)
- akta.pro primary industry
- Life Sciences & Biotechnology Congresses (THAHAJAB)
Keywords
Where The Conference Forum is headquartered
LocationHeadquarters
- HQ city
- New York
- HQ country
- United States
- HQ region
- North America
Offices2 records
Markets served
The Conference Forum business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Operations, Marketing or Sales, Technology or R&D, Others
Revenue model
- Conference and Event Registration: Revenue from conference attendance fees including early bird pricing, group discounts, and standard registration fees for events like PODD, DPHARM, and other industry conferences
- Sponsorships and Exhibits: Revenue from pharmaceutical, biotech, and drug delivery companies sponsoring and exhibiting at conferences
- Marketing Services: Digital content, branding, and advertising services for the medicine development ecosystem
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| One time/ perpetual license | Pay-as-you-go | Standard conference registration |
| One time/ perpetual license | Pay-as-you-go | Early bird pricing |
| One time/ perpetual license | Pay-as-you-go | Group discount (3+ attendees) |
| One time/ perpetual license | Pay-as-you-go | Non-profit discount |
Go-to-market motion1 record
Distribution channels2 records
Marketing channels6 records
The Conference Forum product offering
Product offeringCore offering
The Conference Forum operates a portfolio of established annual conferences for the pharmaceutical, biotechnology, and drug delivery industries, including PODD (Partnership Opportunities in Drug Delivery), DPHARM, Patients as Partners in Clinical Research, CMO Summit 360, Immuno-Oncology 360, CRAACO, Partnerships with Clinical Sites, Community-Based Clinical Trials, and Women Leadership in Biotech. It complements these events with the PharmaTalkRadio podcast, on-demand video webcasts, editorial articles, and digital marketing services for the medicine development ecosystem. The company now operates as a brand under Fierce Life Sciences following its 2025 acquisition by Questex.
Product overview
The Conference Forum is a platform of established conferences for the pharma, biotech, and drug delivery industries, now part of Fierce Life Sciences (Questex). The portfolio includes multiple specialized conferences (DPHARM, PODD, Patients as Partners, CMO Summit 360°, CRAACO, Partnerships with Clinical Sites, Immuno-Oncology 360°, Women Leadership in Biotech, Community-Based Clinical Trials, Drug Delivery) complemented by multimedia content including PharmaTalkRadio podcasts, videos/webcasts, editorial articles, and marketing services. The company also acquired Versalinx Global Events to expand its life sciences portfolio.
Differentiator
Problem solved
Functional benefit
Brands
- PODD: Partnership Opportunities in Drug Delivery: Conference focused on drug delivery innovation and partnering opportunities in the pharma/biotech industry
- DPHARM: Disruptive Innovations
- CRAACO: Clinical Research as a Care Option
- PharmaTalkRadio
Quantifiable outcome
- PODD 2025 convened 1,000+ attendees from pharma, biotech, drug delivery, academia, and investors
- +1 more outcomes
Companies that use The Conference Forum
Customer profileNamed customers11 records
Segments4 records
Ideal customer profiles3 records
The Conference Forum technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature1 record
The Conference Forum partnerships and signals
Strategic signalPartnerships
Two partnerships are on record, tiered core.
- QuestexcoreQuestex, a healthcare and life sciences company, acquired The Conference Forum and Versalinx Global Events in November 2025 to expand its portfolio within the booming $88.2 billion life sciences industry. The acquisition included research-driven events and conferences focused on clinical trials, immuno-oncology, patient treatment, and drug delivery.
- Fierce Life SciencescoreThe Conference Forum joined Fierce Life Sciences, combining resources to provide greater market reach, more networking, and partnering opportunities. Fierce Life Sciences includes Fierce Pharma, Fierce Biotech, and Fierce Healthcare media brands that cross-promote content and events.
Scale indicators2 records
Recent moves5 records
Expansion highlights5 records
The Conference Forum competitors and assessment
Company assessmentBroad incumbents
- Reuters Events Pharma: Large media-affiliated pharma event series (Pharma EU, Patient Engagement) leveraging Reuters' reach. Competes for the same senior pharma R&D and commercial audience as The Conference Forum's conferences.
- Pharma Intelligence (Informa): Informa's life sciences intelligence arm, combining industry data, analytics, and editorial with sponsored events. A broader incumbent that competes for the same pharma marketing and audience budgets as The Conference Forum's marketing services line.
Others
- BIO (Biotechnology Innovation Organization): Largest biotech industry trade association, organizer of the BIO International Convention — the flagship global biotech partnering event. Adjacent to The Conference Forum's biotech/drug delivery audience rather than a direct competitor.
Direct peers
- Hanson Wade: Specialist in running niche life sciences and drug development conferences (e.g., World Orphan Drug Congress). Targets the same senior pharma/biotech executive audience with a similar curated, high-touch model.
- Informa: Largest global B2B events and information company with a deep pharma and life sciences portfolio (CPhI, Pharma Intelligence, IBC, CBI, Arena). Informa is the most direct competitor in the life sciences conference market and offers the same enterprise sponsor/attendee model as The Conference Forum.
- Arena International: Runs B2B conferences for pharma, biotech, and clinical operations (e.g., Outsourcing in Clinical Trials series). Direct competitor in clinical trial-focused events alongside DPHARM.
- ExL Events: Operates specialty life sciences and pharma events (now part of Informa), including programs in clinical operations, medical affairs, and drug safety — overlapping with The Conference Forum's clinical trial and drug delivery tracks.
- Cambridge Healthtech Institute (CHI): Long-standing organizer of specialized life sciences conferences (PEGS, Molecular Medicine, SCOPE) targeted at pharma/biotech R&D and clinical operations professionals. Direct competitor in the niche pharma conference category.
- Drug Information Association (DIA): Global life sciences membership organization running major annual conferences (DIA Global, DIA Europe) focused on drug development, regulatory, and clinical research. Overlaps directly with DPHARM and Patients as Partners.
- CBI (now Informa Connect): Life sciences and healthcare conference organizer (now Informa Connect) producing events for pharma compliance, medical affairs, and clinical operations. Overlaps with The Conference Forum's clinical and drug delivery events.
Market position
Strengths4 records
Weaknesses4 records
Competitive moat4 records
Key risks6 records
Key highlights6 records
Customer concentration
The Conference Forum social profiles
Digital presenceThe Conference Forum financial estimates
Financial estimateRevenue estimate
Valuation estimate
The Conference Forum leadership team
Management profileNumber of profiles
The Conference Forum funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
The Conference Forum M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about The Conference Forum
What does The Conference Forum do?
The Conference Forum operates a portfolio of established annual conferences for the pharmaceutical, biotechnology, and drug delivery industries, including PODD (Partnership Opportunities in Drug Delivery), DPHARM, Patients as Partners in Clinical Research, CMO Summit 360, Immuno-Oncology 360, CRAACO, Partnerships with Clinical Sites, Community-Based Clinical Trials, and Women Leadership in Biotech. It complements these events with the PharmaTalkRadio podcast, on-demand video webcasts, editorial articles, and digital marketing services for the medicine development ecosystem. The company now operates as a brand under Fierce Life Sciences following its 2025 acquisition by Questex.
Is The Conference Forum a public or private company?
The Conference Forum is a private company. It is classified as corporate owned and is currently operating.
When was The Conference Forum founded?
The Conference Forum was founded in 2011. It employs 11 to 50 people.
Where is The Conference Forum based?
The Conference Forum is headquartered in New York, United States, in the North America region.
How does The Conference Forum make money?
Three revenue lines are on record. Conference and Event Registration is the primary driver. The others are sponsorships and Exhibits and marketing Services.
Who are The Conference Forum's main competitors?
Broad incumbents on record are Reuters Events Pharma and Pharma Intelligence (Informa). BIO (Biotechnology Innovation Organization) is listed as an others. Direct peers are Hanson Wade, Informa, Arena International, ExL Events, Cambridge Healthtech Institute (CHI), Drug Information Association (DIA) and CBI (now Informa Connect).
Does The Conference Forum have an API?
No public API is recorded for The Conference Forum.
What industry is The Conference Forum in?
The Conference Forum's product category is Life Sciences Conferences and Events. Its primary akta.pro industry code is THAHAJAB, Life Sciences & Biotechnology Congresses. Its NAICS code is 5417 and its SIC code is 8731.